Armina Fortuna Riethmuller

Armina Fortuna Riethmuller is a seasoned professional in pharmacovigilance and drug safety, currently serving as Senior Director and European Qualified Person for Pharmacovigilance at Idorsia Pharmaceuticals Ltd since March 2021. Previously, Armina held key positions at The Janssen Pharmaceutical Companies of Johnson & Johnson as Director of Pharmacovigilance Systems Oversight and at Actelion as Director and Deputy EU QPPV, managing safety profiles, compliance, and operational activities. Armina's extensive experience includes roles at Roche and Novartis in pharmacovigilance auditing and compliance, and a solid foundation as a psychiatric nurse at Universitäre Psychiatrische Kliniken Basel. Education includes a Master of Science in Pharmacovigilance from the University of Hertfordshire and a Bachelor of Science in Nursing from Lyceum of Batangas in the Philippines.